BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 36076951)

  • 1. The Role of RNA-Binding Proteins in Hematological Malignancies.
    Aguilar-Garrido P; Otero-Sobrino Á; Navarro-Aguadero MÁ; Velasco-Estévez M; Gallardo M
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA-binding proteins in hematopoiesis and hematological malignancy.
    Hodson DJ; Screen M; Turner M
    Blood; 2019 May; 133(22):2365-2373. PubMed ID: 30967369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA Regulators in Leukemia and Lymphoma.
    Prieto C; Kharas MG
    Cold Spring Harb Perspect Med; 2020 May; 10(5):. PubMed ID: 31615866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting immune checkpoints in hematological malignancies.
    Salik B; Smyth MJ; Nakamura K
    J Hematol Oncol; 2020 Aug; 13(1):111. PubMed ID: 32787882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression, Regulation and Function of microRNA as Important Players in the Transition of MDS to Secondary AML and Their Cross Talk to RNA-Binding Proteins.
    Bauer M; Vaxevanis C; Heimer N; Al-Ali HK; Jaekel N; Bachmann M; Wickenhauser C; Seliger B
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32992663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of non-coding RNAs in hematological malignancies.
    Ghafouri-Fard S; Esmaeili M; Taheri M
    Eur J Pharmacol; 2020 May; 875():172976. PubMed ID: 32112777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The research progress of circular RNAs in hematological malignancies.
    Ji T; Chen Q; Tao S; Shi Y; Chen Y; Shen L; Wang C; Yu L
    Hematology; 2019 Dec; 24(1):727-731. PubMed ID: 31581903
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of circular RNAs in hematological malignancies.
    Lin Z; Long F; Zhao M; Zhang X; Yang M
    Genomics; 2020 Nov; 112(6):4000-4008. PubMed ID: 32634468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding proteins as drivers of AML and novel therapeutic targets.
    Qin T; Cheng Y; Wang X
    Leuk Lymphoma; 2022 May; 63(5):1045-1057. PubMed ID: 35075986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advance of research on survivin in hematological malignancies--review].
    Xiong HX; Chen BA; Ding JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):866-9. PubMed ID: 15631681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional crosstalk between RNA-binding proteins and noncoding RNAs in cancer biology.
    Li L; Miao H; Chang Y; Yao H; Zhao Y; Wu F; Song X
    Semin Cancer Biol; 2021 Oct; 75():84-96. PubMed ID: 33722631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Immunology in Hematological Disorders.
    Takami A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.
    Yang XJ; Xi YM; Li ZJ
    Biomed Res Int; 2019; 2019():4860268. PubMed ID: 31032347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug resistance-related microRNAs in hematological malignancies: translating basic evidence into therapeutic strategies.
    Xie L; Jing R; Qi J; Lin Z; Ju S
    Blood Rev; 2015 Jan; 29(1):33-44. PubMed ID: 25263425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of exosomes in hematological malignancies.
    Pandian SRK; Vijayakumar KK; Kunjiappan S; Babkiewicz E; Maszczyk P
    Clin Exp Med; 2023 Aug; 23(4):1123-1136. PubMed ID: 35798882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering the role of RNA-binding proteins in the post-transcriptional control of gene expression.
    Kishore S; Luber S; Zavolan M
    Brief Funct Genomics; 2010 Dec; 9(5-6):391-404. PubMed ID: 21127008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The rise of apoptosis: targeting apoptosis in hematologic malignancies.
    Valentin R; Grabow S; Davids MS
    Blood; 2018 Sep; 132(12):1248-1264. PubMed ID: 30012635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of controlling nutritional status score in hematological malignancies.
    Zhang Y; Chen Q; Lu C; Yu L
    Hematology; 2022 Dec; 27(1):653-658. PubMed ID: 35622088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New sequencing methodologies reveal interplay between multiple RNA-binding proteins and their RNAs.
    Melamed S
    Curr Genet; 2020 Aug; 66(4):713-717. PubMed ID: 32193580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.